Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Surveillance Materials & Resources

Historical Comparisons of Vaccine Preventable Disease Morbidity in the United States

A comparison of the morbidity and mortality before and after widespread implementation of national vaccine recommendations for 13 vaccine-preventable diseases for which recommendations were in place prior to 2005.

Manuscript

Roush SW, Murphy TV, Vaccine-Preventable Disease Table Working Group a. Historical Comparisons of Morbidity and Mortality for Vaccine-Preventable Diseases in the United States. JAMA. 2007; 298(19): 2155-2163. Doi:10.1001/jama.298.18.2155.

Presentation Slides

These slides are updated annually to provide vaccine-preventable disease surveillance data for

References

 

Surveillance of Vaccine-Preventable Diseases (VPDs): Update 2017

View recordings and associated files

Goal

To enhance the surveillance of VPDs.

Target Audiences

Public health staff (including epidemiologists, program managers, etc.), health educators, laboratorians, physicians, nurses, physician assistants, and anyone else involved in surveillance and reporting of VPDs.

Presentations

  • Session I: CDC subject matter experts for viral VPDs (mumps, acute flaccid myelitis/polio, varicella, measles, and rotavirus)
  • Session II: CDC subject matter experts for bacterial VPDs (meningococcal disease, pertussis, invasive pneumococcal disease, Haemophilus influenzae, and diphtheria)

 

Investigation and Control of Mumps Outbreaks on College Campuses: Indiana, 2016

In this video, Pam Pontones, State Epidemiologist and Director of the Epidemiology Resource Center at the Indiana State Department of Health, shares her insight regarding a series of mumps outbreaks at college campuses in Indiana during 2016. This Indiana example illustrates challenges in the investigation and control of mumps outbreaks. In addition, this video provides information about the epidemiology of mumps as well as the effectiveness of various public health interventions.

 

Collecting a Buccal Swab Clinical Specimen for Mumps Diagnostic Testing

This video demonstrates how to correctly collect and transport a buccal swab for the detection of mumps virus RNA. Buccal swabs are the preferred sample for confirmation of mumps infection. Ideally, a buccal swab should be collected 1-3 days after symptom onset but may be collected up to 5 days after symptom onset. The audience for the video is healthcare providers.

 

Surveillance of Vaccine-Preventable Diseases Course

Broadcast February 2012

This self-study program provides information on case investigation, outbreak control, and disease reporting for vaccine-preventable diseases. The course highlights the most epidemiologically important data to collect and discusses methods of enhancing surveillance and completing case investigations.

TOP